Does Rallies show Form 4 insider transactions for YCBD?

Yes. Rallies tracks YCBD insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is YCBD research on Rallies investment advice?

No. Rallies provides research, data, and educational context for YCBD. It does not provide personalized investment advice.

YCBD (cbdMD, Inc. Common Stock) Stock Analysis - Insider Trades

cbdMD, Inc. Common Stock (YCBD) is a publicly traded Healthcare sector company. As of May 21, 2026, YCBD trades at $0.74 with a market cap of $8.08M and a P/E ratio of 5.17. YCBD moved -2.64% today. Year to date, YCBD is -33.21%; over the trailing twelve months it is -20.00%. Its 52-week range spans $0.47 to $6.54. Analyst consensus is buy with an average price target of $2.00. Rallies surfaces YCBD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading YCBD stock inside the company?

Recent YCBD insider activity includes Crosnoe Clark R. sold 461.73K, Crosnoe Clark R. sold 69.88K, Crosnoe Clark R. sold 19.10K, and Kennedy Thomas Ronan sold 5.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

YCBD Key Metrics

Key financial metrics for YCBD
Metric	Value
Price	$0.74
Market Cap	$8.08M
P/E Ratio	5.17
EPS	$0.14
Dividend Yield	0.00%
52-Week High	$6.54
52-Week Low	$0.47
Volume	1.12K
Avg Volume	0
Revenue (TTM)	$19.98M
Net Income	$-2.66M
Gross Margin	59.38%

Recent YCBD Insider Trades

Crosnoe Clark R. sold 461.73K (~$1.07M) on Dec 17, 2025.
Crosnoe Clark R. sold 69.88K (~$163.81K) on Dec 17, 2025.
Crosnoe Clark R. sold 19.10K (~$44.78K) on Dec 17, 2025.
Kennedy Thomas Ronan sold 5.00K (~$10.50K) on May 3, 2023.

Latest YCBD News

cbdMD Q2 Revenue Rises 19% to $5.64M Despite EPS Miss — May 15, 2026
cbdMD Unveils Clinical Channel to Supply Hemp CBD Under CMS BEI Incentive — Apr 1, 2026
cbdMD Reports 12% Sequential Revenue Growth, Closes Bluebird Botanicals Deal — Feb 17, 2026

YCBD Analyst Consensus

1 analysts cover YCBD: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $2.00.

Common questions about YCBD

Who is trading YCBD stock inside the company?: Recent YCBD insider activity includes Crosnoe Clark R. sold 461.73K, Crosnoe Clark R. sold 69.88K, Crosnoe Clark R. sold 19.10K, and Kennedy Thomas Ronan sold 5.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for YCBD?: Yes. Rallies tracks YCBD insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is YCBD research on Rallies investment advice?: No. Rallies provides research, data, and educational context for YCBD. It does not provide personalized investment advice.